Welcome to the McGill Antimicrobial Resistance Centre! Antimicrobial Resistance (AMR) is one of the top ten global public health threats. It is an urgent and complex problem that poses major health and economic threats, both within Canada and worldwide. Tackling this impending public health crisis demands innovative, interdisciplinary, and collaborative research solutions that no single sector or approach can address alone.
AMR Centre Events and Announcements
25-26 MIF Awards and MIF-AMR supplemental Awards
Application window is September 22 to November 14, 2025. Encouraging teams that are working to address AMR (e.g. diagnostics, therapeutics, prevention, antimicrobial stewardship) to apply.
7th Annual MI4 Scientific Symposium
"Solutions to Antimicrobial Resistance"
Join us at the McGill Faculty Club on November 19, 2025 from 11:30 am - 5:30 pm with Stewart Cole, Executive Chair of the Ineos Oxford Institute.
View the program and RSVP by November 7th!
Organized by bioMerieux in partnership with EPIC (U. Toronto), McGill AMR Centre and Can-AMR-Net, for more information.
Poster abstract application deadline is October 31, 2025.
Canadian Academy of Health Sciences (CAHS), Report: Assessment on Antimicrobial Resistance and Antimicrobial Use in Food Producing Animals | March 2025
This document presents a new WHO initiative to strengthen diagnostic capacity to improve the diagnosis and management of bacterial and fungal infections and associated AMR.
This bootcamp video series will help participants make the transition from academic and grant-based research to quality compliant product development, and learn the fundamentals for moving an IVD product from concept through development.
Antimicrobials have been an important pillar of our medical system since the 1930s. In addition, they play an enormous role in our food-supply system as they are used to treat, control, and prevent disease in agricultural animals that improve production, health, and reproduction. Agriculture accounts for about 82% of antibiotic use in Canada.
However, antimicrobial resistance (AMR) is becoming an increasingly concerning global issue. There were about 4.95 million deaths associated with bacterial AMR in 2019 . This is a major problem for the stability of our health care system!
McGill Innovation Fund launches 4th edition with major support from Desjardins
North America’s largest co-operative financial group to contribute $500,000 for entrepreneurial competition’s top-tier awards
Spotlight on the McGill AMR Centre!
"McGill AMR Centre: Tackling the global threat of antimicrobial resistance through collaborative and interdisciplinary research"
Antibiotic-Free Treatment for Infection?
New Technology with Potential in the Fight Against Antimicrobial Resistance
New treatment under development could potentially treat intracellular infections without the need for traditional antibiotics.
